Page last updated: 2024-11-06

mitomycin and Cardiac Diseases

mitomycin has been researched along with Cardiac Diseases in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"Two percent had congestive heart failure associated with doxorubicin."1.27Early and delayed clinical cardiotoxicity of doxorubicin. ( Blumenschein, GR; Buzdar, AU; Marcus, C; Smith, TL, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorr, RT1
Shipp, NG1
Liddil, JD1
Iyengar, BS1
Kunz, KR1
Remers, WA1
Buzdar, AU1
Marcus, C1
Smith, TL1
Blumenschein, GR1

Other Studies

2 other studies available for mitomycin and Cardiac Diseases

ArticleYear
Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:1

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Depression, Chemica

1992
Early and delayed clinical cardiotoxicity of doxorubicin.
    Cancer, 1985, Jun-15, Volume: 55, Issue:12

    Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclo

1985